TY - JOUR
T1 - Guidance toward the implementation of multicriteria decision analysis framework in developing countries
AU - Inotai, András
AU - Nguyen, Huong Thanh
AU - Hidayat, Budi
AU - Nurgozhin, Talgat
AU - Kiet, Pham Huy Tuan
AU - Campbell, Jonathan D.
AU - Németh, Bertalan
AU - Maniadakis, Nikos
AU - Brixner, Diana
AU - Wijaya, Kalman
AU - Kaló, Zoltán
N1 - Publisher Copyright:
© 2018, © 2018 Informa UK Limited, trading as Taylor & Francis Group.
PY - 2018/11/2
Y1 - 2018/11/2
N2 - Introduction: Multiple Criteria Decision Analysis (MCDA) is increasingly used in health care mainly because it moves decision-making from ad hoc to an evidence-based and comprehensive process. Developing countries with more restricted financial and human research capacities, however, should consider their own methods of MCDA development and implementation. Areas covered: An MCDA framework to improve procurement decisions of off-patent pharmaceuticals was developed for developing countries and adapted to Indonesia, Kazakhstan and Vietnam during three policy workshops. Based on the experience of these workshops and one joint workshop with international experts and decision makers from multiple developing countries, general recommendations were formulated on how to implement MCDA specifically in developing countries. We provide 17 practical MCDA implementation recommendations in four major areas, including (1) MCDA objectives; (2) technical considerations of MCDA tool; (3) development and customization of MCDA tool and (4) policy implementation of MCDA in decision-making. Expert commentary: These practical MCDA recommendations for developing countries contribute to feasible, transparent, stepwise, iterative and standardized decision-making in health care.
AB - Introduction: Multiple Criteria Decision Analysis (MCDA) is increasingly used in health care mainly because it moves decision-making from ad hoc to an evidence-based and comprehensive process. Developing countries with more restricted financial and human research capacities, however, should consider their own methods of MCDA development and implementation. Areas covered: An MCDA framework to improve procurement decisions of off-patent pharmaceuticals was developed for developing countries and adapted to Indonesia, Kazakhstan and Vietnam during three policy workshops. Based on the experience of these workshops and one joint workshop with international experts and decision makers from multiple developing countries, general recommendations were formulated on how to implement MCDA specifically in developing countries. We provide 17 practical MCDA implementation recommendations in four major areas, including (1) MCDA objectives; (2) technical considerations of MCDA tool; (3) development and customization of MCDA tool and (4) policy implementation of MCDA in decision-making. Expert commentary: These practical MCDA recommendations for developing countries contribute to feasible, transparent, stepwise, iterative and standardized decision-making in health care.
KW - Decision Making
KW - Developing Countries
KW - Implementation Guidance
KW - Multiple Criteria Decision Analysis
KW - Off-patent Pharmaceuticals
UR - http://www.scopus.com/inward/record.url?scp=85052302223&partnerID=8YFLogxK
U2 - 10.1080/14737167.2018.1508345
DO - 10.1080/14737167.2018.1508345
M3 - Article
C2 - 30092151
AN - SCOPUS:85052302223
SN - 1473-7167
VL - 18
SP - 585
EP - 592
JO - Expert Review of Pharmacoeconomics and Outcomes Research
JF - Expert Review of Pharmacoeconomics and Outcomes Research
IS - 6
ER -